AlphaMaven AlphaMaven

Wonder's $650m raise, Crypto.com's $20b valuation, Angelini Pharma seals rare disease buy

Reported by Axios
Jul 16, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Wonder, a NYC-based cloud kitchen operator, secured $650 million in Series D funding at a $9 billion valuation, attracting prominent institutional investors including Accel, GV, New Enterprise Associates, AllianceBernstein, ARK Invest, and Kayne Anderson Rudnick Investment Management.
  • • Fora, an NYC-based travel booking platform, raised $60 million in Series D funding at a $1 billion valuation, with backing from Forerunner, Tactile Ventures, Thrive Capital, Insight Partners, and a roster of emerging venture firms and high-profile limited partners including Amy Schumer.
  • • A broad wave of venture funding across enterprise AI, healthcare software, and specialized verticals reflected sustained institutional appetite for AI-enabled platforms, with Bunkerhill Health ($55 million), Sable ($45 million), and Corner Health ($32.5 million) completing significant rounds led by established tier-one venture firms.
  • • Crypto.com reached a $20 billion valuation (per publisher context), signaling continued capital formation in digital assets despite broader market volatility.
  • • Angelini Pharma completed an acquisition in rare diseases therapeutics, adding pharmaceutical M&A to a dealmaking period dominated by software and AI-driven business models.
Summary
The week of July 16, 2026 witnessed significant capital deployment across venture markets, with Wonder's $650 million Series D closing at a $9 billion valuation serving as the largest single transaction. The cloud kitchen operator's raise attracted a diversified group of institutional LPs, including venture-focused firms (Accel, GV, NEA), asset managers (AllianceBernstein, ARK Invest), and alternative investment managers (Kayne Anderson Rudnick), indicating broad confidence in the unit economics and growth trajectory of cloud-based restaurant infrastructure.

Concurrent with Wonder's close, Fora—a travel booking platform—raised $60 million in Series D at a $1 billion valuation, reaching unicorn status. The round was led by Forerunner and Tactile Ventures, with participation from Thrive Capital and Insight Partners, alongside emerging venture funds and notable individual LPs. This valuation reflects a resurgence in travel-tech investment despite post-pandemic market normalization and suggests investor conviction in platform consolidation within the travel vertical.

Enterprise AI continued to attract substantial capital allocation. Bunkerhill Health, an agentic AI platform serving health systems, closed $55 million across seed-to-Series B tranches with lead backing from Khosla Ventures and co-investment from Sequoia Capital, Felicis, Optum Ventures, and Y Combinator. Sable, a customer communications AI company, raised $45 million led by Sequoia Capital and 8VC. Corner Health, a practice management software provider, completed a $32.5 million raise led by Oak HC/FT. These closings underscore sustained tier-one venture appetite for healthcare software and AI-driven operational platforms, particularly where solutions address regulatory compliance or provider workflow optimization.

Additional transactions included Whale, a San Francisco enterprise AI company, which completed a $40 million Series C extension, while American Growth Insurance, an AI-powered insurance brokerage roll-up, raised $70 million. Angelini Pharma's rare disease acquisition and Crypto.com's $20 billion valuation round out a period marked by diversified dealmaking across healthcare, digital assets, and AI-augmented business services.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Axios Wonder's $650m raise, Crypto.com's $20b valuation, Angelini Pharma seals rare disease buy